TORONTO and GLIL YAM,
Israel, Aug. 6, 2024 /PRNewswire/ -- IM Cannabis Corp.
(CSE: IMCC) (NASDAQ: IMCC) (the "Company",
"IMCannabis", or "IMC"), a leading medical cannabis
company with operations in Israel
and Germany, will report
operational and financial results for the second quarter 2024 ended
June 30, 2024, on Wednesday, August 14, 2024, before the market
opens.
The Company will host a zoom web conference on the same day at
9:00am ET to discuss the results,
followed by a question-and-answer session for the investment
community. Investors are invited to register by clicking here. All
relevant information will be sent upon registration.
If you are unable to join us live, a recording of the call will
be available on our website at https://investors.imcannabis.com/
within 24 hours after the call.
Link for the to register for the zoom call:
https://us02web.zoom.us/webinar/register/WN_W9nYbBB4R7CREuqN9dGOag
About IM Cannabis Corp.
IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis
company that provides premium cannabis products to medical patients
in Israel and Germany, two of the largest medical cannabis
markets. The Company has focused its resources to achieve
sustainable and profitable growth in its highest value markets,
Israel and Germany. The Company leverages a transnational
ecosystem powered by a unique data-driven approach and a globally
sourced product supply chain. With an unwavering commitment to
responsible growth and compliance with the strictest regulatory
environments, the Company strives to amplify its commercial and
brand power to become a global high-quality cannabis player.
The IMC ecosystem operates in Israel through Focus Medical Herbs Ltd., which
imports and distributes cannabis to medical patients, leveraging
years of proprietary data and patient insights. The Company also
operates medical cannabis retail pharmacies, online platforms,
distribution centers, and logistical hubs in Israel that enable the safe delivery and
quality control of IMC products throughout the entire value chain.
In Germany, the IMC ecosystem
operates through Adjupharm GmbH, where it distributes cannabis to
pharmacies for medical cannabis patients.
Company Contact:
Anna Taranko, Director Investor
& Public Relations
IM Cannabis Corp.
+49 157 80554338
a.taranko@imcannabis.de
Oren Shuster, CEO
IM Cannabis Corp.
+972-77-3603504
info@imcannabis.com
Logo -
https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/im-cannabis-to-report-second-quarter-2024-financial-results-on-wednesday-august-14th-at-900am-et-302215415.html